APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Esomeprazole Capsule

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Esomeprazole Capsule Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025193 pages

Choose your research edition.

Industry ResearchEsomeprazole Capsule Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Esomeprazole Capsule Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Esomeprazole Capsule Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Esomeprazole Capsule Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Esomeprazole Capsule Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Esomeprazole Capsule market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Esomeprazole Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Esomeprazole Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Esomeprazole Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Esomeprazole Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Esomeprazole Capsule include Teva., Sandoz, Sanofi, Novartis, Mylan, Stada, Saval Pharmaceutical, Mepha and KernPharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Esomeprazole Capsule market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Esomeprazole Capsule and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Esomeprazole Capsule sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Esomeprazole Capsule market size, projected growth trends, production technologies, key applications, and end-use industries.

Esomeprazole Capsule Segment by Company

Teva.

Sandoz

Sanofi

Novartis

Mylan

Stada

Saval Pharmaceutical

Mepha

KernPharm

Garmish Pharmaceuticals

CQ Lummy

Blaskov

AstraZeneca AB

Actavis

Esomeprazole Capsule Segment by Type

Short-Term Use

Long-Term Use

Esomeprazole Capsule Segment by Application

Duodenal Ulcers

Gastroesophageal Reflux Disease

Others

Esomeprazole Capsule Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Esomeprazole Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Esomeprazole Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Esomeprazole Capsule.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Esomeprazole Capsule market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Esomeprazole Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Esomeprazole Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Esomeprazole Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Esomeprazole Capsule Industry Trends Table 2. Esomeprazole Capsule Industry Drivers Table 3. Esomeprazole Capsule Industry Opportunities and Challenges Table 4. Esomeprazole Capsule Industry Restraints Table 5. Global Esomeprazole Capsule Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Esomeprazole Capsule Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Esomeprazole Capsule Sales by Manufacturers (K Pcs) & (2021-2026) Table 8. Global Esomeprazole Capsule Sales Market Share by Manufacturers Table 9. Global Esomeprazole Capsule Average Sales Price (US$/pc) of Manufacturers (2021-2026) Table 10. Global Esomeprazole Capsule Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Esomeprazole Capsule Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Esomeprazole Capsule Manufacturers, Product Type & Application Table 13. Global Esomeprazole Capsule Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Esomeprazole Capsule by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Short-Term Use Table 17. Major Manufacturers of Long-Term Use Table 18. Global Esomeprazole Capsule Sales by Type 2021 VS 2025 VS 2032 (K Pcs) Table 19. Global Esomeprazole Capsule Sales by Type (2021-2026) & (K Pcs) Table 20. Global Esomeprazole Capsule Sales by Type (2027-2032) & (K Pcs) Table 21. Global Esomeprazole Capsule Sales Market Share by Type (2021-2026) Table 22. Global Esomeprazole Capsule Sales Market Share by Type (2027-2032) Table 23. Global Esomeprazole Capsule Revenue by Type 2021 VS 2025 VS 2032 (K Pcs) Table 24. Global Esomeprazole Capsule Revenue by Type (2021-2026) & (K Pcs) Table 25. Global Esomeprazole Capsule Revenue by Type (2027-2032) & (K Pcs) Table 26. Global Esomeprazole Capsule Revenue Market Share by Type (2021-2026) Table 27. Global Esomeprazole Capsule Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Duodenal Ulcers Table 29. Major Manufacturers of Gastroesophageal Reflux Disease Table 30. Major Manufacturers of Others Table 31. Global Esomeprazole Capsule Sales by Application 2021 VS 2025 VS 2032 (K Pcs) Table 32. Global Esomeprazole Capsule Sales by Application (2021-2026) & (K Pcs) Table 33. Global Esomeprazole Capsule Sales by Application (2027-2032) & (K Pcs) Table 34. Global Esomeprazole Capsule Sales Market Share by Application (2021-2026) Table 35. Global Esomeprazole Capsule Sales Market Share by Application (2027-2032) Table 36. Global Esomeprazole Capsule Revenue by Application 2021 VS 2025 VS 2032 (K Pcs) Table 37. Global Esomeprazole Capsule Revenue by Application (2021-2026) & (K Pcs) Table 38. Global Esomeprazole Capsule Revenue by Application (2027-2032) & (K Pcs) Table 39. Global Esomeprazole Capsule Revenue Market Share by Application (2021-2026) Table 40. Global Esomeprazole Capsule Revenue Market Share by Application (2027-2032) Table 41. Global Esomeprazole Capsule Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 42. Global Esomeprazole Capsule Sales by Region (2021-2026) & (K Pcs) Table 43. Global Esomeprazole Capsule Sales Market Share by Region (2021-2026) Table 44. Global Esomeprazole Capsule Sales Forecasted by Region (2027-2032) & (K Pcs) Table 45. Global Esomeprazole Capsule Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Esomeprazole Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 47. North America Esomeprazole Capsule Sales by Country (2021-2026) & (K Pcs) Table 48. North America Esomeprazole Capsule Sales by Country (2027-2032) & (K Pcs) Table 49. Europe Esomeprazole Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 50. Europe Esomeprazole Capsule Sales by Country (2021-2026) & (K Pcs) Table 51. Europe Esomeprazole Capsule Sales by Country (2027-2032) & (K Pcs) Table 52. Asia Pacific Esomeprazole Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 53. Asia Pacific Esomeprazole Capsule Sales by Country (2021-2026) & (K Pcs) Table 54. Asia Pacific Esomeprazole Capsule Sales by Country (2027-2032) & (K Pcs) Table 55. South America, Middle East and Africa Esomeprazole Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 56. South America, Middle East and Africa Esomeprazole Capsule Sales by Country (2021-2026) & (K Pcs) Table 57. South America, Middle East and Africa Esomeprazole Capsule Sales by Country (2027-2032) & (K Pcs) Table 58. Global Esomeprazole Capsule Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Esomeprazole Capsule Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Esomeprazole Capsule Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Esomeprazole Capsule Revenue Market Share by Region (2021-2026) Table 62. Global Esomeprazole Capsule Revenue Market Share by Region (2027-2032) Table 63. Teva. Company Information Table 64. Teva. Business Overview Table 65. Teva. Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva. Esomeprazole Capsule Product Portfolio Table 67. Teva. Recent Development Table 68. Sandoz Company Information Table 69. Sandoz Business Overview Table 70. Sandoz Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sandoz Esomeprazole Capsule Product Portfolio Table 72. Sandoz Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sanofi Esomeprazole Capsule Product Portfolio Table 77. Sanofi Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Novartis Esomeprazole Capsule Product Portfolio Table 82. Novartis Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Mylan Esomeprazole Capsule Product Portfolio Table 87. Mylan Recent Development Table 88. Stada Company Information Table 89. Stada Business Overview Table 90. Stada Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Stada Esomeprazole Capsule Product Portfolio Table 92. Stada Recent Development Table 93. Saval Pharmaceutical Company Information Table 94. Saval Pharmaceutical Business Overview Table 95. Saval Pharmaceutical Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Saval Pharmaceutical Esomeprazole Capsule Product Portfolio Table 97. Saval Pharmaceutical Recent Development Table 98. Mepha Company Information Table 99. Mepha Business Overview Table 100. Mepha Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Mepha Esomeprazole Capsule Product Portfolio Table 102. Mepha Recent Development Table 103. KernPharm Company Information Table 104. KernPharm Business Overview Table 105. KernPharm Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. KernPharm Esomeprazole Capsule Product Portfolio Table 107. KernPharm Recent Development Table 108. Garmish Pharmaceuticals Company Information Table 109. Garmish Pharmaceuticals Business Overview Table 110. Garmish Pharmaceuticals Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Garmish Pharmaceuticals Esomeprazole Capsule Product Portfolio Table 112. Garmish Pharmaceuticals Recent Development Table 113. CQ Lummy Company Information Table 114. CQ Lummy Business Overview Table 115. CQ Lummy Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. CQ Lummy Esomeprazole Capsule Product Portfolio Table 117. CQ Lummy Recent Development Table 118. Blaskov Company Information Table 119. Blaskov Business Overview Table 120. Blaskov Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Blaskov Esomeprazole Capsule Product Portfolio Table 122. Blaskov Recent Development Table 123. AstraZeneca AB Company Information Table 124. AstraZeneca AB Business Overview Table 125. AstraZeneca AB Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. AstraZeneca AB Esomeprazole Capsule Product Portfolio Table 127. AstraZeneca AB Recent Development Table 128. Actavis Company Information Table 129. Actavis Business Overview Table 130. Actavis Esomeprazole Capsule Sales (K Pcs), Price (US$/pc), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Actavis Esomeprazole Capsule Product Portfolio Table 132. Actavis Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Esomeprazole Capsule Distributors List Table 136. Esomeprazole Capsule Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Esomeprazole Capsule Product Image Figure 2. Global Esomeprazole Capsule Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Esomeprazole Capsule Market Size (2021-2032) & (US$ Million) Figure 4. Global Esomeprazole Capsule Sales (2021-2032) & (K Pcs) Figure 5. Global Esomeprazole Capsule Average Price (US$/pc) & (2021-2032) Figure 6. Global Top 5 and 10 Esomeprazole Capsule Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Short-Term Use Image Figure 9. Long-Term Use Image Figure 10. Global Esomeprazole Capsule Sales by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 11. Global Esomeprazole Capsule Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Esomeprazole Capsule Sales Market Share by Type (2021-2032) Figure 13. Global Esomeprazole Capsule Revenue by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 14. Global Esomeprazole Capsule Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Esomeprazole Capsule Revenue Market Share by Type (2021-2032) Figure 16. Duodenal Ulcers Image Figure 17. Gastroesophageal Reflux Disease Image Figure 18. Others Image Figure 19. Global Esomeprazole Capsule Sales by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 20. Global Esomeprazole Capsule Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Esomeprazole Capsule Sales Market Share by Application (2021-2032) Figure 22. Global Esomeprazole Capsule Revenue by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 23. Global Esomeprazole Capsule Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Esomeprazole Capsule Revenue Market Share by Application (2021-2032) Figure 25. North America Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 26. North America Esomeprazole Capsule Sales Market Share by Country (2021-2032) Figure 27. U.S. Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 28. Canada Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 29. Mexico Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 30. Europe Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 31. Europe Esomeprazole Capsule Sales Market Share by Country (2021-2032) Figure 32. Germany Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 33. France Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 34. U.K. Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 35. Italy Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 36. Netherlands Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 37. Asia Pacific Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 38. Asia Pacific Esomeprazole Capsule Sales Market Share by Country (2021-2032) Figure 39. China Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 40. Japan Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 41. South Korea Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 42. Southeast Asia Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 43. India Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 44. Australia Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 45. South America, Middle East and Africa Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 46. South America, Middle East and Africa Esomeprazole Capsule Sales Market Share by Country (2021-2032) Figure 47. Brazil Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 48. South Africa Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 49. Saudi Arabia Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 50. Turkey Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 51. Argentina Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 52. UAE Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 53. Egypt Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 54. Chile Esomeprazole Capsule Sales and Growth Rate (2021-2032) & (K Pcs) Figure 55. Global Esomeprazole Capsule Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Esomeprazole Capsule Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Esomeprazole Capsule Revenue (2021-2032) & (US$ Million) Figure 58. North America Esomeprazole Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Esomeprazole Capsule Revenue (2021-2032) & (US$ Million) Figure 60. Europe Esomeprazole Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Esomeprazole Capsule Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Esomeprazole Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Esomeprazole Capsule Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Esomeprazole Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Esomeprazole Capsule Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Esomeprazole Capsule Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Short-Term Use
  • Long-Term Use
Applications
  • Duodenal Ulcers
  • Gastroesophageal Reflux Disease
  • Others
Companies covered
  • Teva.
  • Sandoz
  • Sanofi
  • Novartis
  • Mylan
  • Stada
  • Saval Pharmaceutical
  • Mepha
  • KernPharm
  • Garmish Pharmaceuticals
  • CQ Lummy
  • Blaskov
  • AstraZeneca AB
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Esomeprazole Capsule Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Esomeprazole Capsule Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Esomeprazole Capsule Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Esomeprazole Capsule Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Esomeprazole Capsule Market Dynamics
  1. 2.1 Esomeprazole Capsule Industry Trends
  2. 2.2 Esomeprazole Capsule Industry Drivers
  3. 2.3 Esomeprazole Capsule Industry Opportunities and Challenges
  4. 2.4 Esomeprazole Capsule Industry Restraints
3 Esomeprazole Capsule Market by Manufacturers
  1. 3.1 Global Esomeprazole Capsule Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Esomeprazole Capsule Sales by Manufacturers (2021-2026)
  3. 3.3 Global Esomeprazole Capsule Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Esomeprazole Capsule Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Esomeprazole Capsule Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Esomeprazole Capsule Manufacturers, Product Type & Application
  7. 3.7 Global Esomeprazole Capsule Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Esomeprazole Capsule Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Esomeprazole Capsule Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Esomeprazole Capsule Tier 1, Tier 2, and Tier 3
4 Esomeprazole Capsule Market by Type
  1. 4.1 Esomeprazole Capsule Type Introduction
  2. 4.1.1 Short-Term Use
  3. 4.1.2 Long-Term Use
  4. 4.2 Global Esomeprazole Capsule Sales by Type
  5. 4.2.1 Global Esomeprazole Capsule Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Esomeprazole Capsule Sales by Type (2021-2032)
  7. 4.2.3 Global Esomeprazole Capsule Sales Market Share by Type (2021-2032)
  8. 4.3 Global Esomeprazole Capsule Revenue by Type
  9. 4.3.1 Global Esomeprazole Capsule Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Esomeprazole Capsule Revenue by Type (2021-2032)
  11. 4.3.3 Global Esomeprazole Capsule Revenue Market Share by Type (2021-2032)
5 Esomeprazole Capsule Market by Application
  1. 5.1 Esomeprazole Capsule Application Introduction
  2. 5.1.1 Duodenal Ulcers
  3. 5.1.2 Gastroesophageal Reflux Disease
  4. 5.1.3 Others
  5. 5.2 Global Esomeprazole Capsule Sales by Application
  6. 5.2.1 Global Esomeprazole Capsule Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Esomeprazole Capsule Sales by Application (2021-2032)
  8. 5.2.3 Global Esomeprazole Capsule Sales Market Share by Application (2021-2032)
  9. 5.3 Global Esomeprazole Capsule Revenue by Application
  10. 5.3.1 Global Esomeprazole Capsule Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Esomeprazole Capsule Revenue by Application (2021-2032)
  12. 5.3.3 Global Esomeprazole Capsule Revenue Market Share by Application (2021-2032)
6 Global Esomeprazole Capsule Sales by Region
  1. 6.1 Global Esomeprazole Capsule Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Esomeprazole Capsule Sales by Region (2021-2032)
  3. 6.2.1 Global Esomeprazole Capsule Sales by Region (2021-2026)
  4. 6.2.2 Global Esomeprazole Capsule Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Esomeprazole Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Esomeprazole Capsule Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Esomeprazole Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Esomeprazole Capsule Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Esomeprazole Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Esomeprazole Capsule Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Esomeprazole Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Esomeprazole Capsule Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Esomeprazole Capsule Revenue by Region
  1. 7.1 Global Esomeprazole Capsule Revenue by Region
  2. 7.1.1 Global Esomeprazole Capsule Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Esomeprazole Capsule Revenue by Region (2021-2026)
  4. 7.1.3 Global Esomeprazole Capsule Revenue by Region (2027-2032)
  5. 7.1.4 Global Esomeprazole Capsule Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Esomeprazole Capsule Revenue (2021-2032)
  8. 7.2.2 North America Esomeprazole Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Esomeprazole Capsule Revenue (2021-2032)
  11. 7.3.2 Europe Esomeprazole Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Esomeprazole Capsule Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Esomeprazole Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Esomeprazole Capsule Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Esomeprazole Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva.
  2. 8.1.1 Teva. Company Information
  3. 8.1.2 Teva. Business Overview
  4. 8.1.3 Teva. Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva. Esomeprazole Capsule Product Portfolio
  6. 8.1.5 Teva. Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Esomeprazole Capsule Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Esomeprazole Capsule Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Esomeprazole Capsule Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Esomeprazole Capsule Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Stada
  32. 8.6.1 Stada Company Information
  33. 8.6.2 Stada Business Overview
  34. 8.6.3 Stada Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Stada Esomeprazole Capsule Product Portfolio
  36. 8.6.5 Stada Recent Developments
  37. 8.7 Saval Pharmaceutical
  38. 8.7.1 Saval Pharmaceutical Company Information
  39. 8.7.2 Saval Pharmaceutical Business Overview
  40. 8.7.3 Saval Pharmaceutical Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Saval Pharmaceutical Esomeprazole Capsule Product Portfolio
  42. 8.7.5 Saval Pharmaceutical Recent Developments
  43. 8.8 Mepha
  44. 8.8.1 Mepha Company Information
  45. 8.8.2 Mepha Business Overview
  46. 8.8.3 Mepha Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mepha Esomeprazole Capsule Product Portfolio
  48. 8.8.5 Mepha Recent Developments
  49. 8.9 KernPharm
  50. 8.9.1 KernPharm Company Information
  51. 8.9.2 KernPharm Business Overview
  52. 8.9.3 KernPharm Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 KernPharm Esomeprazole Capsule Product Portfolio
  54. 8.9.5 KernPharm Recent Developments
  55. 8.10 Garmish Pharmaceuticals
  56. 8.10.1 Garmish Pharmaceuticals Company Information
  57. 8.10.2 Garmish Pharmaceuticals Business Overview
  58. 8.10.3 Garmish Pharmaceuticals Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Garmish Pharmaceuticals Esomeprazole Capsule Product Portfolio
  60. 8.10.5 Garmish Pharmaceuticals Recent Developments
  61. 8.11 CQ Lummy
  62. 8.11.1 CQ Lummy Company Information
  63. 8.11.2 CQ Lummy Business Overview
  64. 8.11.3 CQ Lummy Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CQ Lummy Esomeprazole Capsule Product Portfolio
  66. 8.11.5 CQ Lummy Recent Developments
  67. 8.12 Blaskov
  68. 8.12.1 Blaskov Company Information
  69. 8.12.2 Blaskov Business Overview
  70. 8.12.3 Blaskov Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Blaskov Esomeprazole Capsule Product Portfolio
  72. 8.12.5 Blaskov Recent Developments
  73. 8.13 AstraZeneca AB
  74. 8.13.1 AstraZeneca AB Company Information
  75. 8.13.2 AstraZeneca AB Business Overview
  76. 8.13.3 AstraZeneca AB Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AstraZeneca AB Esomeprazole Capsule Product Portfolio
  78. 8.13.5 AstraZeneca AB Recent Developments
  79. 8.14 Actavis
  80. 8.14.1 Actavis Company Information
  81. 8.14.2 Actavis Business Overview
  82. 8.14.3 Actavis Esomeprazole Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Actavis Esomeprazole Capsule Product Portfolio
  84. 8.14.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Esomeprazole Capsule Value Chain Analysis
  2. 9.1.1 Esomeprazole Capsule Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Esomeprazole Capsule Production Mode & Process
  6. 9.2 Esomeprazole Capsule Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Esomeprazole Capsule Distributors
  9. 9.2.3 Esomeprazole Capsule Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst